Clinical Report: Retrospective Study of Pediatric Methylmalonic Acidemia
Overview
This study analyzed clinical features and genetic profiles of 79 pediatric patients with methylmalonic acidemia (MMA) in China. Key findings include the identification of various phenotypes, genotypes, and biochemical abnormalities, highlighting the heterogeneity of MMA and the importance of early diagnosis and management.
Background
Methylmalonic acidemia is a significant hereditary metabolic disorder that can lead to severe neurological and developmental issues in affected children. Understanding its clinical and genetic characteristics is crucial for optimizing treatment strategies and improving patient outcomes. This study contributes valuable data to enhance early diagnosis and management of MMA in pediatric populations.
Data Highlights
Characteristic
Findings
Patients with combined MMA
47
Patients with isolated MMA
32
Most common mutation in combined MMA
c.609G>A
Most common mutation in isolated MMA
c.729_730insTT
Reported mutation sites in combined MMA
89
Reported mutation sites in isolated MMA
64
Key Findings
Symptoms of MMA can appear at any age, with early-onset patients experiencing more severe manifestations.
Common symptoms include delayed growth, motor disorders, intellectual disability, vomiting, and feeding difficulties.
Patients with combined MMA and hyperhomocysteinemia showed more frequent central nervous system abnormalities on MRI.
Isolated MMA patients exhibited a higher incidence of hyperglycemia and vomiting.
Regular treatment led to significant improvements in motor and intellectual disabilities for early diagnosed patients.
Clinical Implications
Healthcare professionals should be vigilant for the signs of MMA in pediatric patients, especially those presenting with non-specific symptoms. Early diagnosis and intervention are critical for improving outcomes, and genetic testing should be considered to guide management strategies.
Conclusion
This study underscores the clinical heterogeneity of methylmalonic acidemia and emphasizes the need for tailored diagnostic and treatment approaches to enhance patient care.
